Concepedia

T. Crofts

TC

Statistics

Publications

8

Citations

1.4K

H-Index

8

Active since

2002

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

T. Crofts is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, oncology, and pharmacology.

Publications per year

2002–2009

8

Publications

8

Phase III Trial Comparing Supportive Care Alone With Supportive Care With Oral Topotecan in Patients With Relapsed Small-Cell Lung Cancer

Mary O’Brien, Tudor–Eliade Ciuleanu, H. Tsekov et al. · Journal of Clinical Oncology · 2006 · 639 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma

Thomas E. Hutson, Ian D. Davis, Jean‐Pascal Machiels et al. · Journal of Clinical Oncology · 2009 · 293 citations

Medicine, Pharmacology, Pharmacotherapy +14

Open-Label, Multicenter, Randomized, Phase III Study Comparing Oral Topotecan/Cisplatin Versus Etoposide/Cisplatin As Treatment for Chemotherapy-Naive Patients With Extensive-Disease Small-Cell Lung Cancer

John R. Eckardt, Joachim von Pawel, Zsolt Pápai et al. · Journal of Clinical Oncology · 2006 · 147 citations · Full text

Medicine, Oncology, Pharmacology +10

Short Course of Omeprazole

William M. Pandak, Shahwali Arezo, Sharon Everett et al. · Journal of Clinical Gastroenterology · 2002 · 103 citations

Medicine, Internal Medicine, Pharmacotherapy +13

Biomarker analysis and final efficacy and safety results of a phase II renal cell carcinoma trial with pazopanib (GW786034), a multi-kinase angiogenesis inhibitor

Thomas E. Hutson, Ian D. Davis, J. H. Machiels et al. · Journal of Clinical Oncology · 2008 · 85 citations

Medicine, Oncology, Pharmacology +17

1–5 of 8